Juan Uríz

2.4k total citations
12 papers, 1.6k citations indexed

About

Juan Uríz is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Juan Uríz has authored 12 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Juan Uríz's work include Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Organ Transplantation Techniques and Outcomes (7 papers). Juan Uríz is often cited by papers focused on Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Organ Transplantation Techniques and Outcomes (7 papers). Juan Uríz collaborates with scholars based in Spain and United States. Juan Uríz's co-authors include Vicente Arroyo, Pere Ginès, Andrés Cárdenas, B. Calahorra, Wladimiro Jiménez, Ramón Bataller, Juan Rodés, Juan Rodés, Rolando Ortega and Dara De Las Heras and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Juan Uríz

12 papers receiving 1.6k citations

Peers

Juan Uríz
Juan Uríz
Citations per year, relative to Juan Uríz Juan Uríz (= 1×) peers B. Calahorra

Countries citing papers authored by Juan Uríz

Since Specialization
Citations

This map shows the geographic impact of Juan Uríz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Uríz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Uríz more than expected).

Fields of papers citing papers by Juan Uríz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Uríz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Uríz. The network helps show where Juan Uríz may publish in the future.

Co-authorship network of co-authors of Juan Uríz

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Uríz. A scholar is included among the top collaborators of Juan Uríz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Uríz. Juan Uríz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Leache, Leire, Marta Gutiérrez‐Valencia, Luis Carlos Saiz, et al.. (2022). Meta‐analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis. Alimentary Pharmacology & Therapeutics. 57(6). 620–634. 5 indexed citations
2.
Zozaya, José Manuel, et al.. (2020). Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents. Gastroenterología y Hepatología. 43(5). 248–255. 5 indexed citations
3.
Guevara, Mónica, María E. Baccaro, José Ríos, et al.. (2010). Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver International. 30(8). 1137–1142. 75 indexed citations
4.
Ginès, Pere, Juan Uríz, B. Calahorra, et al.. (2002). Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 123(6). 1839–1847. 368 indexed citations
5.
Ortega, Rolando, Pere Ginès, Juan Uríz, et al.. (2002). Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study. Hepatology. 36(4). 941–948. 388 indexed citations
6.
Uríz, Juan, Pere Ginès, Rolando Ortega, et al.. (2002). Increased plasma levels of neuropeptide Y in hepatorenal syndrome. Journal of Hepatology. 36(3). 349–355. 18 indexed citations
7.
Sánchez‐Fueyo, Alberto, et al.. (2001). Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Liver Transplantation. 7(2). 106–112. 26 indexed citations
8.
Fernández‐Esparrach, Glòria, Alberto Sánchez‐Fueyo, Pere Ginès, et al.. (2001). A prognostic model for predicting survival in cirrhosis with ascites. Journal of Hepatology. 34(1). 46–52. 193 indexed citations
9.
Cárdenas, Andrés, Pere Ginès, Juan Uríz, et al.. (2001). Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 34(4). 671–676. 227 indexed citations
10.
Uríz, Juan, Andrés Cárdenas, & Vicente Arroyo. (2000). Pathophysiology, diagnosis and treatment of ascites in cirrhosis. Best Practice & Research Clinical Gastroenterology. 14(6). 927–943. 9 indexed citations
11.
Uríz, Juan, Pere Ginès, Andrés Cárdenas, et al.. (2000). Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. Journal of Hepatology. 33(1). 43–48. 275 indexed citations
12.
Cárdenas, Andrés, Juan Uríz, Pere Ginès, & Vicente Arroyo. (2000). Hepatorenal syndrome. Liver Transplantation. 6(Supplement 1). S63–S71. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026